152 related articles for article (PubMed ID: 8423081)
1. Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.
Siegel SA; Evans ME; Pollack M; Leone AO; Kinney CS; Tam SH; Daddona PE
Infect Immun; 1993 Feb; 61(2):512-9. PubMed ID: 8423081
[TBL] [Abstract][Full Text] [Related]
2. The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).
Tonoli M; Davies KA; Norsworthy PJ; Cohen J; Walport MJ
Clin Exp Immunol; 1993 May; 92(2):232-8. PubMed ID: 8485908
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.
Mascelli MA; Frederick B; Ely T; Neblock DS; Shealy DJ; Pak KY; Daddona PE
Infect Immun; 1993 May; 61(5):1756-63. PubMed ID: 8478065
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria.
Evans ME; Pollack M; Hardegen NJ; Koles NL; Guelde G; Chia JK
J Infect Dis; 1990 Jul; 162(1):148-55. PubMed ID: 2355191
[TBL] [Abstract][Full Text] [Related]
5. Characterization of specific binding of a human immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain.
Fujihara Y; Lei MG; Morrison DC
Infect Immun; 1993 Mar; 61(3):910-8. PubMed ID: 8432611
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-lipid A IgM antibodies HA-1A and E-5 recognize distinct epitopes on lipopolysaccharide and lipid A.
Fujihara Y; Bogard WC; Lei MG; Daddona PE; Morrison DC
J Infect Dis; 1993 Dec; 168(6):1429-35. PubMed ID: 7504034
[TBL] [Abstract][Full Text] [Related]
8. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
Mutharia LM; Crockford G; Bogard WC; Hancock RE
Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
[TBL] [Abstract][Full Text] [Related]
10. The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.
Seelen MA; Athanassiou P; Lynn WA; Norsworthy P; Walport MJ; Cohen J; Davies KA
Immunology; 1995 Apr; 84(4):653-61. PubMed ID: 7790040
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide.
Bogard WC; Siegel SA; Leone AO; Damiano E; Shealy DJ; Ely TM; Frederick B; Mascelli MA; Siegel RC; Machielse B
J Immunol; 1993 May; 150(10):4438-49. PubMed ID: 7683319
[TBL] [Abstract][Full Text] [Related]
12. Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.
Fisher CJ; Zimmerman J; Khazaeli MB; Albertson TE; Dellinger RP; Panacek EA; Foulke GE; Dating C; Smith CR; LoBuglio AF
Crit Care Med; 1990 Dec; 18(12):1311-5. PubMed ID: 2245602
[TBL] [Abstract][Full Text] [Related]
13. Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.
Cornelissen JJ; Mäkel I; Algra A; Benaissa-Trouw BJ; Schellekens JF; Kraaijeveld CA; Verhoef J
J Infect Dis; 1993 Apr; 167(4):876-81. PubMed ID: 8450253
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
16. The HA-1A monoclonal antibody for gram-negative sepsis.
N Engl J Med; 1991 Jul; 325(4):279-83. PubMed ID: 2057029
[No Abstract] [Full Text] [Related]
17. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Hanberger H
Scand J Infect Dis Suppl; 1992; 81():1-52. PubMed ID: 1322561
[TBL] [Abstract][Full Text] [Related]
19. Antilipid A monoclonal antibody HA-1A decreases the capacity of bacterial lipopolysaccharide to activate human vascular endothelial cells by an immune adherence mechanism.
Paleolog EM; Katsikis P; Harris G; Daddona P; Dalesandro MR; Kinney CS; Woody JN; Feldmann M
Cytokine; 1993 Nov; 5(6):570-7. PubMed ID: 7514452
[TBL] [Abstract][Full Text] [Related]
20. Anti-endotoxin human monoclonal antibody A6H4C5 (HA-1A) utilizes the VH4.21 gene.
Bieber MM; Bhat NM; Teng NN
Clin Infect Dis; 1995 Oct; 21 Suppl 2():S186-9. PubMed ID: 8845451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
